Middle East and Africa Coronary and Peripheral Stents Market Outlook (2022-2033)

The Middle East and Africa coronary and peripheral stents market size is expected to reach US$ 327.3 million by 2033 from US$ 232.3 million in 2024. The market is estimated to record a CAGR of 4.0% from 2025 to 2033.

Executive Summary and Middle East and Africa Coronary and Peripheral Stents Market Analysis:

The Middle East and Africa coronary and peripheral stents market is experiencing moderate growth, driven by increasing prevalence of cardiovascular diseases and a rising demand for minimally invasive interventions. Urbanization, lifestyle changes, and the growing incidence of diabetes and hypertension are contributing to higher procedural volumes. Hospitals in major cities are gradually adopting advanced stent technologies, with coronary stents forming the bulk of usage, while peripheral stents are gaining importance for complex vascular cases. Market growth is restrained by uneven healthcare infrastructure, limited access to catheterization laboratories in rural areas, and budget constraints in public hospitals. Import reliance for advanced stent technologies also affects availability and pricing stability. Despite these challenges, government initiatives to improve cardiovascular care, investments in hospital infrastructure, and professional training programs for interventional cardiology are strengthening adoption. Rising awareness among patients and clinicians continues to support the gradual expansion of the stents market across the region.

Middle East and Africa Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.  

Middle East and Africa Coronary and Peripheral Stents Market Outlook

The Middle East and Africa coronary and peripheral stents market is concentrated in urban referral hospitals and specialized cardiac centers, where coronary interventions dominate. Peripheral stent adoption is growing for diabetic vascular complications and complex limb ischemia cases. A key driver of market growth is the expansion of advanced catheterization laboratories and cardiovascular centers in urban areas, supported by government healthcare development programs. Improved access to interventional procedures enables early treatment of coronary and peripheral arterial diseases, reducing reliance on open surgery. Additionally, private healthcare providers and international partnerships are facilitating the adoption of newer-generation stent platforms. Physician training and continuous professional development programs are enhancing procedural confidence and standardizing care. This combination of infrastructure expansion and capacity building is fostering increased demand for both coronary and peripheral stents in the region.

Middle East and Africa Coronary and Peripheral Stents Market Country Insights

Based on country, the Middle East and Africa coronary and peripheral stents market is further segmented into Saudi Arabia, the United Arab Emirates, Kuwait, Bahrain, Qatar, Oman, Turkiye, South Africa, Egypt, Nigeria, Algeria, and Rest of MEA. Turkiye held the largest share in 2024.

Turkiye dominates the Middle East and Africa coronary and peripheral stents market due to its advanced healthcare infrastructure, well-equipped hospitals, and strong interventional cardiology network. Major urban centers have high-capacity cardiac centers performing both coronary and peripheral interventions. Drug-eluting coronary stents are widely adopted as standard care, while peripheral stents are increasingly used for complex vascular and diabetic complications. The country benefits from strong regulatory oversight, robust distributor networks, and collaborations with global stent manufacturers, ensuring consistent product availability. Investments in physician training, standardized treatment protocols, and hospital modernization support procedural efficiency and high clinical outcomes. Although rural and remote regions have limited access, Turkiye’s scale, policy support, and growing interventional capacity firmly establish it as the leading stents market in the Middle East and Africa region.

Middle East and Africa Coronary and Peripheral Stents Market Company Profiles

Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Cook Medical, Meril Life Sciences and Translumina are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Middle East and Africa Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Middle East and Africa Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• European Society of Cardiology
• American College of Cardiology
• American Heart Association
• Asian Pacific Society of Interventional Cardiology
• Company website
• Company annual reports
• Company investor presentations